{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:53:17Z","timestamp":1785426797518,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81641123, 81773552"],"award-info":[{"award-number":["81641123, 81773552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Central Universities","award":["2042017kf0193"],"award-info":[{"award-number":["2042017kf0193"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.phrs.2019.01.036","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T12:48:21Z","timestamp":1547815701000},"page":"551-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"141","author":[{"given":"Zhi-Jiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.01.036_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","article-title":"Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"52","author":"Nathan","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2019.01.036_bib0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.phrs.2019.01.036_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/aje\/kwu124","article-title":"Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis","volume":"180","author":"Zhang","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0020","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2019.01.036_bib0025","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2019.01.036_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/dom.12267","article-title":"The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2019.01.036_bib0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyx046","article-title":"Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation","volume":"46","author":"Farmer","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","article-title":"Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer","volume":"559","author":"Wu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.01.036_bib0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2019.01.036_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/er.2008-0022","article-title":"Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions","volume":"30","author":"Kleinberg","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2019.01.036_bib0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2017.89","article-title":"Biochemical and cellular properties of insulin receptor signalling","volume":"19","author":"Haeusler","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0060","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1158\/1078-0432.CCR-16-3011","article-title":"Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: results from the EPIC cohort","volume":"23","author":"Husing","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2019.01.036_bib0065","first-page":"378","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2019.01.036_bib0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.01.036_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.phrs.2019.01.036_bib0080","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2011.39.3769","article-title":"Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial","volume":"30","author":"Bonanni","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-015-3519-8","article-title":"Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial","volume":"153","author":"Ko","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2019.01.036_bib0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clbc.2012.03.004","article-title":"Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study","volume":"12","author":"Campagnoli","year":"2012","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.phrs.2019.01.036_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/jnci\/djy040","article-title":"The effects of metformin and weight loss on biomarkers associated with breast cancer outcomes","volume":"110","author":"Patterson","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2019.01.036_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-015-3307-5","article-title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","volume":"150","author":"Hadad","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2019.01.036_bib0105","doi-asserted-by":"crossref","first-page":"84224","DOI":"10.18632\/oncotarget.20478","article-title":"A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2019.01.036_bib0110","article-title":"Metformin in neoadjuvant systemic treatment in breast cancer patients with metabolic syndrome","volume":"27","author":"Liubota","year":"2016","journal-title":"Annals of Oncology. Conference: 41st European Society for Medical Oncology Congress, ESMO 2016. Denmark. Conference Start: 20161007. Conference End: 20161011"},{"key":"10.1016\/j.phrs.2019.01.036_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv006","article-title":"Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32","volume":"107","author":"Goodwin","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2019.01.036_bib0120","doi-asserted-by":"crossref","first-page":"35687","DOI":"10.18632\/oncotarget.26286","article-title":"A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study","volume":"9","author":"Martin-Castillo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2019.01.036_bib0125","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-018-05070-2","article-title":"Metformin plus chemotherapy versus chemotherapy alone in the firstline treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial","author":"Nanni","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2019.01.036_bib0130","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/bjc.2013.657","article-title":"The effect of metformin on apoptosis in a breast cancer presurgical trial","volume":"109","author":"Cazzaniga","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2019.01.036_bib0135","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1038\/s41388-018-0145-z","article-title":"Controlling the master-upstream regulation of the tumor suppressor LKB1","volume":"37","author":"Kullmann","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2019.01.036_bib0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2019.01.036_bib0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2019.01.036_bib0150","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/onc.2011.459","article-title":"Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2019.01.036_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2017.11.010","article-title":"Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics","volume":"63","author":"Christopoulos","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2019.01.036_bib0160","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.phrs.2019.01.036_bib0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/09513590.2015.1019342","article-title":"Effects of metformin on the adrenal cortex of androgenized rats","volume":"31","author":"Macedo","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0170","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.bbrc.2017.12.120","article-title":"Follicle-stimulating hormone promotes the transformation of cholesterol to estrogen in mouse adipose tissue","volume":"495","author":"Cui","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.01.036_bib0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2009.09.012","article-title":"Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer","volume":"316","author":"Fortunati","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.phrs.2019.01.036_bib0180","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2741\/e562","article-title":"Obesity and breast cancer: mechanisms and therapeutic implications","volume":"4","author":"Brown","year":"2012","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"10.1016\/j.phrs.2019.01.036_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00592-016-0933-2","article-title":"The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival","volume":"54","author":"Wei","year":"2017","journal-title":"Acta Diabetol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818318589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:01:42Z","timestamp":1760911302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818318589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S1043661818318589"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.01.036","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}